Healthy Returns: Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight

Novo Nordisk released new data showing high-dose Wegovy helped patients lose nearly 28% of their weight, potentially boosting the case for the higher dose version of its obesity injection. This data could have a significant impact on the treatment of obesity. The new information may lead to increased adoption of Wegovy.